{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:52:37Z","timestamp":1775274757825,"version":"3.50.1"},"reference-count":211,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015520","name":"Department of Education and Knowledge","doi-asserted-by":"publisher","award":["AARE18-194"],"award-info":[{"award-number":["AARE18-194"]}],"id":[{"id":"10.13039\/501100015520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejphar.2021.174398","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T12:00:21Z","timestamp":1627560021000},"page":"174398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases"],"prefix":"10.1016","volume":"909","author":[{"given":"Hebaallah Mamdouh","family":"Hashiesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9486-4069","authenticated-orcid":false,"given":"Niraj Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3346-910X","authenticated-orcid":false,"given":"Piyush Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandragouda R.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer N.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-2966","authenticated-orcid":false,"given":"Shreesh K.","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174398_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/acs.chemrev.5b00411","article-title":"Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2 receptor agonists","volume":"116","author":"Aghazadeh Tabrizi","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2021.174398_bib2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1055\/s-0042-112365","article-title":"The effect of muscarinic receptor modulators on the antinociception induced by CB2 receptor agonist, JWH133 in mice","volume":"66","author":"Alipour","year":"2016","journal-title":"Drug Research"},{"key":"10.1016\/j.ejphar.2021.174398_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12974-014-0191-6","article-title":"Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury","volume":"11","author":"Amenta","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2021.174398_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.pain.2008.06.007","article-title":"Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons","volume":"138","author":"Anand","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2021.174398_bib5","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/npp.2012.22","article-title":"Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB2 receptors","volume":"37","author":"Aracil-Fern\u00e1ndez","year":"2012","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3233\/JAD-130137","article-title":"CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in A\u03b2PP\/PS1 mice","volume":"35","author":"Aso","year":"2013","journal-title":"J. Alzheimer's disease : JAD"},{"issue":"3","key":"10.1016\/j.ejphar.2021.174398_bib211","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib7","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s12035-015-9213-3","article-title":"Neuroprotective effect of JZL184 in MPP(+)-Treated SH-SY5Y cells through CB2 receptors","volume":"53","author":"Aymerich","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2021.174398_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35003583","article-title":"Cannabinoids control spasticity and tremor in a multiple sclerosis model","volume":"404","author":"Baker","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.174398_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1542\/peds.2007-0211","article-title":"Neurodevelopmental outcome in survivors of periventricular hemorrhagic infarction","volume":"120","author":"Bassan","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejphar.2021.174398_bib10","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/j.1460-9568.2006.04684.x","article-title":"CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms","volume":"23","author":"Beltramo","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174398_bib11","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174398_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/ACO.0000000000000616","article-title":"An overview of the cannabinoid type 2 receptor system and its therapeutic potential","volume":"31","author":"Bie","year":"2018","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.ejphar.2021.174398_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF03033380","article-title":"Axonal degeneration and progressive neurologic disability in multiple sclerosis","volume":"5","author":"Bjartmar","year":"2003","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.14336\/AD.2015.0617","article-title":"Potential therapeutical contributions of the endocannabinoid system towards aging and alzheimer's disease","volume":"6","author":"Bonnet","year":"2015","journal-title":"Aging and disease"},{"key":"10.1016\/j.ejphar.2021.174398_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/epi.13973","article-title":"Cannabinoids for epilepsy: what do we know and where do we go?","volume":"59","author":"Brodie","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2021.174398_bib16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0707481","article-title":"Novel cannabinoid receptors","volume":"152","author":"Brown","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuroscience.2011.12.028","article-title":"Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury","volume":"203","author":"Brownjohn","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174398_bib18","doi-asserted-by":"crossref","first-page":"e55582","DOI":"10.7554\/eLife.55582","article-title":"Protective role of neuronal and lymphoid cannabinoid CB(2) receptors in neuropathic pain","volume":"9","author":"Caba\u00f1ero","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ejphar.2021.174398_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lfs.2018.11.058","article-title":"Cannabinoid type 2 receptor agonist JWH-133, attenuates Okadaic acid induced spatial memory impairment and neurodegeneration in rats","volume":"217","author":"\u00c7ak\u0131r","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2021.174398_bib20","doi-asserted-by":"crossref","first-page":"105978","DOI":"10.1016\/j.intimp.2019.105978","article-title":"The ameliorating effect of cannabinoid type 2 receptor activation on brain, lung, liver and heart damage in cecal ligation and puncture-induced sepsis model in rats","volume":"78","author":"\u00c7ak\u0131r","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2021.174398_bib21","first-page":"4784","article-title":"CB2R induces a protective response for epileptic seizure via the PI3K 110\u03b1-AKT signaling pathway","volume":"16","author":"Cao","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ejphar.2021.174398_bib22","first-page":"1","article-title":"CB2R induces a protective response against epileptic seizures through ERK and p38 signaling pathways","author":"Cao","year":"2020","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174398_bib23","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1124\/mol.65.4.999","article-title":"Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism","volume":"65","author":"Carrier","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0028-3908(02)00118-1","article-title":"Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence","volume":"43","author":"Casta\u00f1\u00e9","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pnpbp.2016.02.001","article-title":"Treatment-resistant panic disorder: clinical significance, concept and management","volume":"70","author":"Chen","year":"2016","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"key":"10.1016\/j.ejphar.2021.174398_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/aps.2016.149","article-title":"Brain cannabinoid receptor 2: expression, function and modulation","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2021.174398_bib27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.bjp.0707506","article-title":"Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI","volume":"153","author":"Chin","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/imm.12441","article-title":"Endocannabinoid signalling in innate and adaptive immunity","volume":"144","author":"Chiurchi\u00f9","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.ejphar.2021.174398_bib29","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ajpath.2012.11.024","article-title":"Activation of cannabinoid CB2 receptor-mediated AMPK\/CREB pathway reduces cerebral ischemic injury","volume":"182","author":"Choi","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2021.174398_bib30","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1038\/emm.2015.100","article-title":"CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease","volume":"48","author":"Chung","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejphar.2021.174398_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/475027a","article-title":"Grand challenges in global mental health","volume":"475","author":"Collins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.174398_bib32","doi-asserted-by":"crossref","first-page":"17024","DOI":"10.1038\/nrdp.2017.24","article-title":"Anxiety disorders. Nature reviews","volume":"3","author":"Craske","year":"2017","journal-title":"Disease primers"},{"key":"10.1016\/j.ejphar.2021.174398_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/alcalc\/agn079","article-title":"Mechanisms of neurodegeneration and regeneration in alcoholism","volume":"44","author":"Crews","year":"2009","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.ejphar.2021.174398_bib34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2007.10.024","article-title":"Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis","volume":"193","author":"Croxford","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2021.174398_bib35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejphar.2011.06.057","article-title":"Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice","volume":"668","author":"Curto-Reyes","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2012.08.008","article-title":"Effects of Se-phenyl thiazolidine-4-carboselenoate on mechanical and thermal hyperalgesia in brachial plexus avulsion in mice: mediation by cannabinoid CB1 and CB2 receptors","volume":"1475","author":"Del Fabbro","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib37","first-page":"269","article-title":"Attenuation of cocaine-induced conditioned place preference and motor activity via cannabinoid CB2 receptor agonism and CB1 receptor antagonism in rats","volume":"20","author":"Delis","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib38","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1073\/pnas.1118167109","article-title":"Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors","volume":"109","author":"den Boon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2021.174398_bib39","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/jpet.116.232561","article-title":"Functional selectivity of CB2 cannabinoid receptor ligands at a canonical and noncanonical pathway","volume":"358","author":"Dhopeshwarkar","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2021.174398_bib40","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/j.1460-9568.2004.03690.x","article-title":"Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in na\u00efve rats and in rat models of inflammatory and neuropathic pain","volume":"20","author":"Elmes","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174398_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pain.2005.09.005","article-title":"Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat","volume":"118","author":"Elmes","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2021.174398_bib42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1742-2094-9-150","article-title":"Lipopolysaccharide impairs amyloid \u03b2 efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier","volume":"9","author":"Erickson","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2021.174398_bib43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbr.2012.03.020","article-title":"Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?","volume":"231","author":"Farooq","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.etp.2008.04.006","article-title":"The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney. Experimental and toxicologic pathology :","volume":"60","author":"Feizi","year":"2008","journal-title":"official journal of the Gesellschaft fur Toxikologische Pathologie"},{"key":"10.1016\/j.ejphar.2021.174398_bib45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuroscience.2012.01.008","article-title":"Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke","volume":"207","author":"Fern\u00e1ndez-L\u00f3pez","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174398_bib46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tips.2006.11.001","article-title":"Cannabinoid CB2 receptor: a new target for controlling neural cell survival?","volume":"28","author":"Fern\u00e1ndez-Ruiz","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2021.174398_bib47","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.mce.2008.01.001","article-title":"Role of CB2 receptors in neuroprotective effects of cannabinoids","volume":"286","author":"Fern\u00e1ndez-Ruiz","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2021.174398_bib48","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13311-015-0381-7","article-title":"Cannabinoids in neurodegenerative disorders and stroke\/brain Trauma: from preclinical models to clinical applications","volume":"12","author":"Fern\u00e1ndez-Ruiz","year":"2015","journal-title":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics"},{"key":"10.1016\/j.ejphar.2021.174398_bib49","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s11481-011-9291-6","article-title":"Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat","volume":"6","author":"Fraga","year":"2011","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib50","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.1523\/JNEUROSCI.23-21-07767.2003","article-title":"Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility","volume":"23","author":"Franklin","year":"2003","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174398_bib51","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.euroneuro.2012.06.012","article-title":"Cannabinoid 2 receptor- and beta Arrestin 2-dependent upregulation of serotonin 2A receptors","volume":"23","author":"Franklin","year":"2013","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.ejphar.2021.174398_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2015.04.002","article-title":"Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"595","author":"Fu","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2021.174398_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2014.04.034","article-title":"Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats","volume":"342","author":"Fujii","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2021.174398_bib54","first-page":"135","article-title":"Cannabinoid receptor type 2 agonist attenuates acute neurogenic pulmonary edema by preventing neutrophil migration after subarachnoid hemorrhage in rats. Acta neurochirurgica","volume":"121","author":"Fujii","year":"2016","journal-title":"Supplement"},{"key":"10.1016\/j.ejphar.2021.174398_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneuroim.2015.02.008","article-title":"Evaluation of the effects of Eserine and JWH-133 on brain dysfunction associated with experimental endotoxemia","volume":"281","author":"Gamal","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2021.174398_bib56","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","article-title":"Symptom-relieving and neuroprotective effects of the phytocannabinoid \u0394\u2079-THCV in animal models of Parkinson's disease","volume":"163","author":"Garc\u00eda","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0269881110379507","article-title":"Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice","volume":"25","author":"Garc\u00eda-Guti\u00e9rrez","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib58","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1476-5381.2010.00819.x","article-title":"Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors","volume":"160","author":"Garc\u00eda-Guti\u00e9rrez","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib59","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1476-5381.2011.01625.x","article-title":"Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors","volume":"165","author":"Garc\u00eda-Guti\u00e9rrez","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib60","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.neuropharm.2013.05.034","article-title":"Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors","volume":"73","author":"Garc\u00eda-Guti\u00e9rrez","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0960-894X(95)00573-C","article-title":"Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors","volume":"6","author":"Gareau","year":"1996","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2021.174398_bib62","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/bph.14473","article-title":"Opposing roles of CB(1) and CB(2) cannabinoid receptors in the stimulant and rewarding effects of cocaine","volume":"176","author":"Gobira","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib63","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.phrs.2016.03.021","article-title":"Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile","volume":"110","author":"G\u00f3mez-Ca\u00f1as","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib65","first-page":"14","article-title":"Pharmacology of cannabinoids","volume":"25","author":"Grotenhermen","year":"2004","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.ejphar.2021.174398_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.00065","article-title":"Anti-apoptotic and immunomodulatory effect of CB2 agonist, JWH133, in a neonatal rat model of hypoxic-ischemic encephalopathy","volume":"8","author":"Gupta","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ejphar.2021.174398_bib67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pain.2004.10.007","article-title":"Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies","volume":"113","author":"Hansson","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2021.174398_bib68","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1111\/j.1476-5381.2011.01381.x","article-title":"A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia\/reperfusion injury","volume":"165","author":"Horv\u00e1th","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib69","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/01.STR.32.3.696","article-title":"Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month","volume":"32","author":"House","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2021.174398_bib70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/3-540-26573-2_2","article-title":"Cannabinoid receptor signaling","author":"Howlett","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib71","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2021.174398_bib72","doi-asserted-by":"crossref","first-page":"47863","DOI":"10.1074\/jbc.M104068200","article-title":"Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity","volume":"276","author":"Hu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174398_bib73","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11481-011-9306-3","article-title":"Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis","volume":"6","author":"Hu","year":"2011","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib74","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/S0968-0896(99)00219-9","article-title":"3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor","volume":"7","author":"Huffman","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.174398_bib75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.plipres.2016.02.002","article-title":"Endocannabinoids and endocannabinoid-related mediators: targets, metabolism and role in neurological disorders","volume":"62","author":"Iannotti","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib76","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1073\/pnas.1834309100","article-title":"Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS","volume":"100","author":"Ibrahim","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2021.174398_bib77","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41386-020-0696-x","article-title":"Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear","volume":"45","author":"Ivy","year":"2020","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib78","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/FBP.0b013e3282f00c10","article-title":"Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133)-induced antinociception in mice","volume":"18","author":"Jafari","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib79","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1460-9568.2008.06162.x","article-title":"Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats","volume":"27","author":"Jhaveri","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174398_bib80","doi-asserted-by":"crossref","first-page":"134779","DOI":"10.1016\/j.neulet.2020.134779","article-title":"JWH133 inhibits MPP+-induced inflammatory response and iron influx in astrocytes","volume":"720","author":"Jia","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2021.174398_bib81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12974-020-01784-7","article-title":"Exogenous activation of cannabinoid-2 receptor modulates TLR4\/MMP9 expression in a spinal cord ischemia reperfusion rat model","volume":"17","author":"Jing","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2021.174398_bib82","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1476-5381.2011.01386.x","article-title":"Animal models of schizophrenia","volume":"164","author":"Jones","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib83","first-page":"720","article-title":"Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. The Lancet","volume":"11","author":"Keep","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2021.174398_bib84","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1113\/jphysiol.2014.286633","article-title":"Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission","volume":"593","author":"Kim","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2021.174398_bib85","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.euroneuro.2013.10.008","article-title":"The cannabinoid CB\u2082 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain","volume":"24","author":"Klauke","year":"2014","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.ejphar.2021.174398_bib86","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuropharm.2016.03.015","article-title":"Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease","volume":"110","author":"K\u00f6falvi","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib87","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","article-title":"Addiction and the brain antireward system","volume":"59","author":"Koob","year":"2008","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.ejphar.2021.174398_bib88","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1399-6576.2010.02268.x","article-title":"New insights into the pathophysiology of postoperative cognitive dysfunction","volume":"54","author":"Krenk","year":"2010","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ejphar.2021.174398_bib89","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2015.01.051","article-title":"Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system","volume":"284","author":"Kruk-Slomka","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib90","doi-asserted-by":"crossref","first-page":"9815092","DOI":"10.1155\/2016\/9815092","article-title":"Correlations between the memory-related behavior and the level of oxidative stress biomarkers in the mice brain, provoked by an acute administration of CB receptor ligands","volume":"2016","author":"Kruk-Slomka","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.ejphar.2021.174398_bib91","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12640-017-9702-4","article-title":"The impact of CB2 receptor ligands on the MK-801-induced hyperactivity in mice","volume":"31","author":"Kruk-Slomka","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib92","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1385\/JMN:13:1-2:55","article-title":"Anandamides inhibit binding to the muscarinic acetylcholine receptor","volume":"13","author":"Lagalwar","year":"1999","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174398_bib93","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881110367732","article-title":"Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis","volume":"25","author":"Lanciego","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib94","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(14)60496-7","article-title":"Every Newborn: progress, priorities, and potential beyond survival","volume":"384","author":"Lawn","year":"2014","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejphar.2021.174398_bib95","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2021.174398_bib96","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuroscience.2015.10.041","article-title":"Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus","volume":"311","author":"Li","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174398_bib97","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12975-015-0425-7","article-title":"A cannabinoid receptor 2 agonist prevents thrombin-induced blood-brain barrier damage via the inhibition of microglial activation and matrix metalloproteinase expression in rats","volume":"6","author":"Li","year":"2015","journal-title":"Translational stroke research"},{"key":"10.1016\/j.ejphar.2021.174398_bib98","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2018.06.006","article-title":"A cannabinoid receptor 2 agonist reduces blood-brain barrier damage via induction of MKP-1 after intracerebral hemorrhage in rats","volume":"1697","author":"Li","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00112","article-title":"Inflammatory regulation by driving microglial M2 polarization: neuroprotective effects of cannabinoid receptor-2 activation in intracerebral hemorrhage","volume":"8","author":"Lin","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2021.174398_bib100","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1601-183X.2009.00498.x","article-title":"Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands","volume":"8","author":"Liu","year":"2009","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.ejphar.2021.174398_bib101","article-title":"Stat3 inhibition attenuates mechanical allodynia through transcriptional regulation of chemokine expression in spinal astrocytes","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174398_bib102","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00213-015-3917-y","article-title":"2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons","volume":"232","author":"Llorente-Berzal","year":"2015","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.ejphar.2021.174398_bib103","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00213-019-05370-5","article-title":"The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice","volume":"237","author":"Lopes","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib104","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2021.174398_bib105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2019.03.040","article-title":"Mechanisms of cannabinoid CB2 receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area","volume":"42","author":"Ma","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2021.174398_bib106","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1471-4892(02)00004-8","article-title":"CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?","volume":"3","author":"Malan","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib107","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/nn.2430","article-title":"Self-modulation of neocortical pyramidal neurons by endocannabinoids","volume":"12","author":"Marinelli","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174398_bib108","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib109","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-9-8","article-title":"Prolonged oral cannabinoid administration prevents neuroinflammation, lowers \u03b2-amyloid levels and improves cognitive performance in Tg APP 2576 mice","volume":"9","author":"Mart\u00edn-Moreno","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2021.174398_bib110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pbb.2019.06.007","article-title":"Alcohol-induced conditioned place preference is modulated by CB2 cannabinoid receptors and modifies levels of endocannabinoids in the mesocorticolimbic system","volume":"183","author":"Mart\u00edn-S\u00e1nchez","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2021.174398_bib111","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1087057108327329","article-title":"Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter\u2122 \u03b2-arrestin assay","volume":"14","author":"McGuinness","year":"2008","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejphar.2021.174398_bib112","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2009.09.055","article-title":"Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"624","author":"McLaughlin","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib113","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0957-4166(00)86322-3","article-title":"Synthesis of the individual, pharmacologically distinct, enantiomers of a tetrahydrocannabinol derivative","volume":"1","author":"Mechoulam","year":"1990","journal-title":"Tetrahedron: Asymmetry"},{"key":"10.1016\/j.ejphar.2021.174398_bib114","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainresrev.2006.11.003","article-title":"Molecular targets in cerebral ischemia for developing novel therapeutics","volume":"54","author":"Mehta","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2021.174398_bib115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lfs.2017.11.029","article-title":"Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects","volume":"192","author":"Mendiguren","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2021.174398_bib116","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s11481-011-9301-8","article-title":"Cannabinoid neuroimmune modulation of SIV disease","volume":"6","author":"Molina","year":"2011","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib117","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1523\/JNEUROSCI.23-16-06470.2003","article-title":"Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia","volume":"23","author":"Molina-Holgado","year":"2003","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174398_bib118","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcp.2018.07.031","article-title":"Emerging strategies targeting CB(2) cannabinoid receptor: biased agonism and allosterism","volume":"157","author":"Morales","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib119","first-page":"133","article-title":"Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. Best practice & research","volume":"23","author":"Moreira","year":"2009","journal-title":"Clinical endocrinology & metabolism"},{"key":"10.1016\/j.ejphar.2021.174398_bib120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.174398_bib121","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1096\/fj.09-141275","article-title":"Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment","volume":"24","author":"Murikinati","year":"2010","journal-title":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.ejphar.2021.174398_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005953","article-title":"SozRank: a new approach for localizing the epileptic seizure onset zone","volume":"14","author":"Murin","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejphar.2021.174398_bib123","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/bjp.2008.340","article-title":"MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models","volume":"155","author":"Naguib","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib124","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1476-5381.2011.01542.x","article-title":"Cannabinoid CB\u2082 receptor-mediated regulation of impulsive-like behaviour in DBA\/2 mice","volume":"165","author":"Navarrete","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib125","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/npp.2013.157","article-title":"Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotine","volume":"38","author":"Navarrete","year":"2013","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bcp.2018.07.041","article-title":"Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol","volume":"157","author":"Navarrete","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00422","article-title":"Vascular dysfunction in a transgenic model of alzheimer's disease: effects of CB1R and CB2R cannabinoid agonists","volume":"10","author":"Navarro-Dorado","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174398_bib128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2021.174398_bib129","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.1523\/JNEUROSCI.3063-04.2004","article-title":"Temporally specific burstin cell proliferation increases hippocampal neurogenesis in protracted abstinence from alcohol","volume":"24","author":"Nixon","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174398_bib130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.yebeh.2016.11.012","article-title":"Cannabinoids in treatment-resistant epilepsy: a review","volume":"70","author":"O'Connell","year":"2017","journal-title":"Epilepsy & behavior : E&B"},{"key":"10.1016\/j.ejphar.2021.174398_bib131","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","article-title":"Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2021.174398_bib132","doi-asserted-by":"crossref","first-page":"e1640","DOI":"10.1371\/journal.pone.0001640","article-title":"Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects","volume":"3","author":"Onaivi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174398_bib133","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/npp.2011.34","article-title":"Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice","volume":"36","author":"Ortega-Alvaro","year":"2011","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib134","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/npp.2011.34","article-title":"Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice","volume":"36","author":"Ortega-Alvaro","year":"2011","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib135","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1111\/j.1460-9568.2008.06266.x","article-title":"Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation","volume":"27","author":"Patel","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174398_bib136","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1210\/en.2004-0638","article-title":"Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"145","author":"Patel","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2021.174398_bib137","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","volume":"76","author":"Patel","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2021.174398_bib138","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/3-540-26573-2_1","article-title":"Pharmacological actions of cannabinoids","volume":"Volume 168","author":"Pertwee","year":"2005"},{"key":"10.1016\/j.ejphar.2021.174398_bib139","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB\u2081 and CB\u2082","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2021.174398_bib140","doi-asserted-by":"crossref","first-page":"112297","DOI":"10.1016\/j.bbr.2019.112297","article-title":"Ligands of the CB2 cannabinoid receptors augment activity of the conventional antidepressant drugs in the behavioural tests in mice","volume":"378","author":"Poleszak","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib141","doi-asserted-by":"crossref","first-page":"172833","DOI":"10.1016\/j.pbb.2019.172833","article-title":"Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice","volume":"188","author":"Poleszak","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.ejphar.2021.174398_bib142","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s43440-020-00088-0","article-title":"Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice","volume":"72","author":"Poleszak","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2021.174398_bib143","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainres.2008.03.063","article-title":"The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms","volume":"1215","author":"Potenzieri","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib144","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1177\/0271678X16685105","article-title":"PET imaging of cannabinoid type 2 receptors with [(11)C]A-836339 did not evidence changes following neuroinflammation in rats","volume":"37","author":"Pottier","year":"2017","journal-title":"Journal of Cerebral Blood Flow and Metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.ejphar.2021.174398_bib145","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1111\/acer.12894","article-title":"Genetic versus pharmacological assessment of the role of cannabinoid type 2 receptors in alcohol reward-related behaviors","volume":"39","author":"Powers","year":"2015","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib146","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1158\/1535-7163.MCT-09-0448","article-title":"Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer","volume":"8","author":"Qamri","year":"2009","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejphar.2021.174398_bib147","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00000542-200310000-00031","article-title":"Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors","volume":"99","author":"Quartilho","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2021.174398_bib148","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174398_bib149","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4628-11.2012","article-title":"Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions","volume":"32","author":"Ramirez","year":"2012","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174398_bib150","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1189\/jlb.1012523","article-title":"Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists","volume":"93","author":"Ramirez","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2021.174398_bib151","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fncel.2015.00379","article-title":"Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain","volume":"9","author":"Rivera","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174398_bib152","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bcp.2018.08.005","article-title":"Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure","volume":"157","author":"Rivera","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib153","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1007\/s00213-015-3939-5","article-title":"Role of CB2 receptors in social and aggressive behavior in male mice","volume":"232","author":"Rodr\u00edguez-Arias","year":"2015","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.ejphar.2021.174398_bib154","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1460-9568.2005.04206.x","article-title":"Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats","volume":"22","author":"Sagar","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174398_bib155","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00213-017-4537-5","article-title":"Regulation of cannabinoid CB(2) receptor constitutive activity in vivo: repeated treatments with inverse agonists reverse the acute activation of JNK and associated apoptotic signaling in mouse brain","volume":"234","author":"Salort","year":"2017","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.ejphar.2021.174398_bib156","first-page":"5784","article-title":"Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor","volume":"61","author":"S\u00e1nchez","year":"2001","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib157","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","article-title":"Diagnosis and treatment of Parkinson disease: molecules to medicine","volume":"116","author":"Savitt","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2021.174398_bib158","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neuroscience.2012.09.080","article-title":"Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia","volume":"227","author":"Schmidt","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174398_bib159","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/epi.16388","article-title":"Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice","volume":"60","author":"Shapiro","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2021.174398_bib160","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1260353","article-title":"Antiallodynic effects of cannabinoid receptor 2 (CB(2)R) agonists on retrovirus infection-induced neuropathic pain","volume":"2019","author":"Sheng","year":"2019","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.ejphar.2021.174398_bib161","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.110.150409","article-title":"Brain microglial cytokines in neurogenic hypertension","volume":"56","author":"Shi","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2021.174398_bib162","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/HJH.0000000000002342","article-title":"Cannabinoid type 2 receptor agonist JWH133 decreases blood pressure of spontaneously hypertensive rats through relieving inflammation in the rostral ventrolateral medulla of the brain","volume":"38","author":"Shi","year":"2020","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2021.174398_bib163","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1073\/pnas.93.9.3984","article-title":"The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons","volume":"93","author":"Skaper","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2021.174398_bib164","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1038\/ncomms13958","article-title":"Cannabinoid CB(2) receptor ligand profiling reveals biased signalling and off-target activity","volume":"8","author":"Soethoudt","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2021.174398_bib165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1465-9921-12-70","article-title":"Claudins in lung diseases","volume":"12","author":"Soini","year":"2011","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib166","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","article-title":"Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the Hippocampus","volume":"90","author":"Stempel","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2021.174398_bib167","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12974-017-0913-7","article-title":"Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity","volume":"14","author":"Sun","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2021.174398_bib168","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40429-014-0014-y","article-title":"Synthetic cannabinoids: pharmacology, behavioral effects, and abuse potential","volume":"1","author":"Tai","year":"2014","journal-title":"Current Addiction Reports"},{"issue":"1","key":"10.1016\/j.ejphar.2021.174398_bib210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/157488912798842269","article-title":"Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives","volume":"7","author":"Tambaro","year":"2012","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.ejphar.2021.174398_bib169","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2016.10.016","article-title":"Cannabinoid receptor 2 activation restricts fibrosis and alleviates hydrocephalus after intraventricular hemorrhage","volume":"1654","author":"Tan","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib170","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuropharm.2015.04.028","article-title":"Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro","volume":"95","author":"Tang","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib171","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s12035-015-9154-x","article-title":"Minocycline attenuates neonatal germinal-matrix-hemorrhage-induced neuroinflammation and brain edema by activating cannabinoid receptor 2","volume":"53","author":"Tang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2021.174398_bib172","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuropharm.2017.01.027","article-title":"2017. Corrigendum to \"A selective CB2R agonist (JWH133) restores neuronal circuit after Germinal Matrix Hemorrhage in the preterm via CX3CR1(+) microglia\" [Neuropharm","volume":"119","author":"Tang","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib173","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2015.01.025","article-title":"Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model","volume":"1602","author":"Tao","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib174","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbi.2016.05.020","article-title":"Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1\/M2 polarization through the cAMP\/PKA pathway in an experimental GMH rat model","volume":"58","author":"Tao","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2021.174398_bib175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/2050640619889773","article-title":"Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease","volume":"8","author":"Tartakover Matalon","year":"2020","journal-title":"United European gastroenterology journal"},{"key":"10.1016\/j.ejphar.2021.174398_bib176","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/mds.23291","article-title":"Typical cerebral metabolic patterns in neurodegenerative brain diseases","volume":"25","author":"Teune","year":"2010","journal-title":"Movement disorders : official journal of the Movement Disorder Society"},{"key":"10.1016\/j.ejphar.2021.174398_bib177","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ajpath.2011.06.039","article-title":"Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals","volume":"179","author":"Thompson","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2021.174398_bib178","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.neuropharm.2004.12.008","article-title":"Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy","volume":"48","author":"Valenzano","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib179","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0140-6736(07)60153-6","article-title":"Subarachnoid haemorrhage","volume":"369","author":"van Gijn","year":"2007","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejphar.2021.174398_bib180","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ejphar.2021.174398_bib181","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1111\/bph.14337","article-title":"New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism","volume":"175","author":"Vecchio","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib182","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pbb.2013.02.008","article-title":"Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy","volume":"105","author":"Vera","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2021.174398_bib183","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.neuropharm.2019.01.022","article-title":"Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks","volume":"148","author":"Viana","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib184","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-pathol-020712-163927","article-title":"Emerging concepts in Alzheimer's disease","volume":"10","author":"Vinters","year":"2015","journal-title":"Annual review of pathology"},{"key":"10.1016\/j.ejphar.2021.174398_bib185","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1523\/JNEUROSCI.0786-09.2009","article-title":"Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K\/Akt pathway","volume":"29","author":"Viscomi","year":"2009","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174398_bib186","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainresbull.2016.01.006","article-title":"Role of hypothalamic cannabinoid receptors in post-stroke depression in rats","volume":"121","author":"Wang","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2021.174398_bib187","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1007\/s12035-017-0676-2","article-title":"Deletion of type-2 cannabinoid receptor induces alzheimer's disease-like tau pathology and memory impairment through AMPK\/GSK3\u03b2 pathway","volume":"55","author":"Wang","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2021.174398_bib188","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3233\/JAD-180142","article-title":"The down-expression of ACE and IDE exacerbates exogenous amyloid-\u03b2 neurotoxicity in CB2R-\/- mice","volume":"64","author":"Wang","year":"2018","journal-title":"Journal of Alzheimer's disease : JAD"},{"key":"10.1016\/j.ejphar.2021.174398_bib189","first-page":"2914","article-title":"Cannabinoid receptor 2 agonist attenuates blood-brain barrier damage in a rat model of intracerebral hemorrhage by activating the Rac1 pathway","volume":"42","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2021.174398_bib190","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/jpet.301.2.679","article-title":"Resorcinol derivatives: a novel Template for the development of cannabinoid CB1\/CB2 and CB2-selective agonists","volume":"301","author":"Wiley","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2021.174398_bib191","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12031-016-0726-7","article-title":"JWH-133, a selective cannabinoid CB\u2082 receptor agonist, exerts toxic effects on neuroblastoma SH-SY5Y cells","volume":"58","author":"Wojcieszak","year":"2016","journal-title":"Journal of Molecular Neuroscience : MN"},{"key":"10.1016\/j.ejphar.2021.174398_bib192","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.eplepsyres.2018.10.002","article-title":"The spatiotemporal expression changes of CB2R in the hippocampus of rats following pilocarpine-induced status epilepticus","volume":"148","author":"Wu","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib193","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/hep4.1415","article-title":"Liver X receptor \u03b1\u2013induced cannabinoid receptor 2 inhibits ubiquitin-specific peptidase 4 through miR-27b, protecting hepatocytes from TGF-\u03b2","volume":"3","author":"Wu","year":"2019","journal-title":"Hepatology Communications"},{"key":"10.1016\/j.ejphar.2021.174398_bib194","first-page":"475","article-title":"CB2R orchestrates neuronal autophagy through regulation of the mTOR signaling pathway in the hippocampus of developing rats with status epilepticus","volume":"45","author":"Wu","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2021.174398_bib195","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nn.2874","article-title":"Brain cannabinoid CB\u2082 receptors modulate cocaine's actions in mice","volume":"14","author":"Xi","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174398_bib196","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2008.01.010","article-title":"Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain","volume":"583","author":"Yamamoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib197","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ejphar.2021.174398_bib198","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s10753-018-0945-x","article-title":"Selective activation of cannabinoid receptor 2 attenuates myocardial infarction via suppressing NLRP3 inflammasome","volume":"42","author":"Yu","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.ejphar.2021.174398_bib199","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917728227","article-title":"Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain","volume":"13","author":"Yuill","year":"2017","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejphar.2021.174398_bib200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/STROKEAHA.111.631044","article-title":"Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage\/microglial activation concomitant to neuroprotection","volume":"43","author":"Zarruk","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2021.174398_bib201","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1590\/S0103-507X2013000100011","article-title":"Biomarkers in septic encephalopathy: a systematic review of clinical studies","volume":"25","author":"Zenaide","year":"2013","journal-title":"Rev Bras Ter Intensiva"},{"key":"10.1016\/j.ejphar.2021.174398_bib202","doi-asserted-by":"crossref","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2021.174398_bib203","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/npp.2014.297","article-title":"Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats","volume":"40","author":"Zhang","year":"2015","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2021.174398_bib204","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/adb.12367","article-title":"Expression of functional cannabinoid CB(2) receptor in VTA dopamine neurons in rats","volume":"22","author":"Zhang","year":"2017","journal-title":"Addiction Biol."},{"key":"10.1016\/j.ejphar.2021.174398_bib205","doi-asserted-by":"crossref","first-page":"135207","DOI":"10.1016\/j.neulet.2020.135207","article-title":"Activation of cannabinoid receptor 2 protects rat hippocampal neurons against A\u03b2-induced neuronal toxicity","volume":"735","author":"Zhao","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2021.174398_bib206","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/acer.12845","article-title":"Effects of chronic alcohol exposure on the modulation of ischemia-induced glutamate release via cannabinoid receptors in the dorsal Hippocampus","volume":"39","author":"Zheng","year":"2015","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2021.174398_bib207","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1476-5381.2009.00184.x","article-title":"Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain","volume":"157","author":"Zhu","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174398_bib208","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/jbmr.3637","article-title":"Cannabinoid receptor 2 agonist prevents local and systemic inflammatory bone destruction in rheumatoid arthritis","volume":"34","author":"Zhu","year":"2019","journal-title":"Journal of Bone and Mineral Research : the official journal of the American Society for Bone and Mineral Research"},{"key":"10.1016\/j.ejphar.2021.174398_bib209","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1111\/bph.12607","article-title":"Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice","volume":"171","author":"Zoppi","year":"2014","journal-title":"Br. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921005513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921005513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:55:24Z","timestamp":1757976924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921005513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":211,"alternative-id":["S0014299921005513"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174398","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"174398"}}